MedTrace Logo

To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization

NCT02133287 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2019-11-15

No results posted yet for this study

Summary

To evaluate The Safety and Efficacy of 'AVI' Stent Comparing with Firebird2® For Treating Coronary Revascularization.

Conditions

  • Ischemic Heart Disease
  • Myocardial Ischemia
  • Coronary Disease
  • Acute Coronary Syndrome

Interventions

DEVICE

AVI® Arsenic trioxide drug eluting stent delivery system

DEVICE

Firebird2® sirolimus eluting stent system

Sponsors & Collaborators

  • Beijing AmsinoMed Medical Device Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Yong Huo, Prof. · Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2018-06-30
Completion
2022-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02133287 on ClinicalTrials.gov